Literature DB >> 15530372

The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors.

Jeffrey P Shaw1, Zoë Johnson, Frédéric Borlat, Catherine Zwahlen, Andreas Kungl, Karen Roulin, Axel Harrenga, Timothy N C Wells, Amanda E I Proudfoot.   

Abstract

The biological activity of chemokines requires interactions with cell surface proteoglycans. We have determined the structure of the chemokine RANTES (regulated on activation normal T cell expressed) in the presence of heparin-derived disaccharide analogs by X-ray crystallography. These structures confirm the essential role of the BBXB motif in the interaction between the chemokine and the disaccharide. Unexpected interactions were observed in the 30s loop and at the amino terminus. Mutant RANTES molecules were designed to abrogate these interactions and their biological activity examined in vivo. The K45E mutant within the BBXB motif lost the capacity to bind heparin and the ability to elicit cellular recruitment. The Y3A mutant maintained its capacity to bind heparin but was unable to elicit cellular recruitment. Finally, a tetrasaccharide is the smallest oligosaccharide which effectively abolishes the ability of RANTES to recruit cells in vivo. These crystallographic structures provide a description of the molecular interaction of a chemokine with glycosaminoglycans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530372     DOI: 10.1016/j.str.2004.08.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  47 in total

1.  Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity.

Authors:  Paolo Lusso; Luca Vangelista; Raffaello Cimbro; Massimiliano Secchi; Francesca Sironi; Renato Longhi; Marina Faiella; Ornella Maglio; Vincenzo Pavone
Journal:  FASEB J       Date:  2011-01-03       Impact factor: 5.191

Review 2.  Structural NMR of protein oligomers using hybrid methods.

Authors:  Xu Wang; Hsiau-Wei Lee; Yizhou Liu; James H Prestegard
Journal:  J Struct Biol       Date:  2010-11-11       Impact factor: 2.867

3.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

4.  Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.

Authors:  James W Murphy; Yoonsang Cho; Aristidis Sachpatzidis; Chengpeng Fan; Michael E Hodsdon; Elias Lolis
Journal:  J Biol Chem       Date:  2007-01-29       Impact factor: 5.157

Review 5.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

6.  Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers.

Authors:  Luca Vangelista; Massimiliano Secchi; Xiaowen Liu; Angela Bachi; Letong Jia; Qiang Xu; Paolo Lusso
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

7.  The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH.

Authors:  Arunima Singh; Warren C Kett; India C Severin; Isaac Agyekum; Jiana Duan; I Jonathan Amster; Amanda E I Proudfoot; Deirdre R Coombe; Robert J Woods
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

8.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

9.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

10.  Structure of mouse IP-10, a chemokine.

Authors:  Talat Jabeen; Philip Leonard; Haryati Jamaluddin; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.